Arcadia Biosciences, Inc. (RKDA) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
202 COUSTEAU PLACE DAVIS, 95618 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 1311 - Crude Petroleum and Natural Gas (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 4,242 | 11,642 | 20,644 | 28,685 | 25,667 | 25,332 | |||
| Cash and cash equivalent | 4,242 | 6,518 | 20,644 | 28,685 | 14,042 | 8,417 | |||
| Short-term investments | 5,124 | 11,625 | 16,915 | ||||||
| Receivables | 1,894 | (3) | 1,370 | 1,406 | 602 | ||||
| Inventory, net of allowances, customer advances and progress billings | 904 | 1,958 | 2,571 | 4,433 | 3,812 | 1,794 | |||
| Inventory | 904 | 1,958 | 2,571 | 4,433 | 3,812 | 1,794 | |||
| Deferred costs | 226 | ||||||||
| Disposal group, including discontinued operation | 96 | ||||||||
| Asset, held-for-sale, not part of disposal group | 51 | 87 | |||||||
| Other undisclosed current assets | 2,106 | 1,321 | 2,099 | 900 | 811 | 486 | |||
| Total current assets: | 9,242 | 14,972 | 25,398 | 35,388 | 31,696 | 28,440 | |||
| Noncurrent Assets | |||||||||
| Inventory, Noncurrent | 3,354 | 767 | 2,494 | 3,485 | 364 | ||||
| Operating lease, right-of-use asset | 137 | 792 | 1,848 | 3,081 | 5,826 | 1,963 | |||
| Property, plant and equipment | 41 | 384 | 704 | 2,291 | 3,539 | 1,799 | |||
| Long-term investments and receivables | 3,966 | ||||||||
| Accounts and financing receivable, after allowance for credit loss | 3,966 | ||||||||
| Intangible assets, net (including goodwill) | 39 | 39 | 40 | 484 | 778 | ||||
| Goodwill | 408 | ||||||||
| Intangible assets, net (excluding goodwill) | 39 | 39 | 40 | 484 | 370 | ||||
| Restricted cash and investments | 2,001 | ||||||||
| Other noncurrent assets | 92 | 164 | 165 | 180 | 23 | 8 | |||
| Total noncurrent assets: | 4,275 | 4,733 | 3,524 | 8,530 | 15,652 | 4,134 | |||
| TOTAL ASSETS: | 13,517 | 19,705 | 28,922 | 43,918 | 47,348 | 32,574 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 2,108 | 2,410 | 2,881 | 3,638 | 4,105 | 4,685 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 1,606 | 1,489 | 1,290 | ||
| Accounts payable | 703 | 801 | 931 | 1,411 | 726 | 492 | |||
| Accrued liabilities | 1,180 | 1,391 | 1,746 | 271 | 592 | 598 | |||
| Other undisclosed accounts payable and accrued liabilities | 225 | 218 | 204 | 350 | 1,298 | 2,305 | |||
| Deferred revenue | 8 | 42 | |||||||
| Debt | 1,141 | 635 | |||||||
| Other liabilities | 270 | 264 | 263 | 306 | |||||
| Due to related parties | ✕ | ✕ | ✕ | 48 | 64 | 80 | 40 | ||
| Other undisclosed current liabilities | 455 | 1,180 | 1,010 | 1,074 | 717 | ||||
| Total current liabilities: | 2,563 | 3,590 | 4,209 | 5,040 | 6,314 | 5,708 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 2,220 | 7,494 | 1,604 | ||||||
| Long-term debt, excluding current maturities | 2,105 | 107 | |||||||
| Liabilities, other than long-term debt | 2,000 | 2,155 | 3,007 | 2,070 | 2,280 | 2,000 | |||
| Other liabilities | 2,000 | 2,000 | 2,000 | 2,070 | 2,280 | 2,000 | |||
| Operating lease, liability | 155 | 1,007 | 2,220 | 5,389 | 1,497 | ||||
| Other undisclosed noncurrent liabilities | 2,731 | 1,257 | 806 | 3,392 | 2,708 | 14,936 | |||
| Total noncurrent liabilities: | 4,731 | 3,412 | 3,813 | 7,682 | 12,482 | 18,540 | |||
| Total liabilities: | 7,294 | 7,002 | 8,022 | 12,722 | 18,796 | 24,248 | |||
| Equity | |||||||||
| Equity, attributable to parent | 6,223 | 12,841 | 21,033 | 31,093 | 27,725 | 7,705 | |||
| Common stock | 65 | 65 | 65 | 63 | 54 | 49 | |||
| Additional paid in capital | 285,036 | 284,515 | 278,827 | 257,515 | 239,496 | 214,826 | |||
| Accumulated other comprehensive income | 101 | 1 | |||||||
| Accumulated deficit | (278,878) | (271,840) | (257,859) | (226,485) | (211,825) | (207,171) | |||
| Equity, attributable to noncontrolling interest | (138) | (133) | 103 | 827 | 621 | ||||
| Total equity: | 6,223 | 12,703 | 20,900 | 31,196 | 28,552 | 8,326 | |||
| TOTAL LIABILITIES AND EQUITY: | 13,517 | 19,705 | 28,922 | 43,918 | 47,348 | 32,574 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 5,045 | 5,330 | 9,956 | 6,780 | 8,034 | 1,169 | ||
| Cost of revenue | (3,028) | (3,393) | (9,802) | (13,390) | (4,311) | (304) | ||
| Cost of product and service sold | (2,963) | (3,300) | (9,802) | (8,708) | (4,311) | (304) | ||
| Gross profit: | 2,017 | 1,937 | 154 | (6,610) | 3,723 | 865 | ||
| Operating expenses | (5,665) | (15,875) | (19,557) | (28,916) | (20,812) | (20,550) | ||
| Other undisclosed operating income | 588 | 4,311 | 304 | |||||
| Operating loss: | (3,648) | (13,938) | (18,815) | (35,526) | (12,778) | (19,381) | ||
| Nonoperating income (Other Nonoperating income) | 31 | 48 | 33 | 10,114 | 740 | 466 | ||
| Interest and debt expense | (20) | (682) | (5) | |||||
| Loss from continuing operations before equity method investments, income taxes: | (3,617) | (13,890) | (18,782) | (25,432) | (12,720) | (18,920) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (692) | 733 | 3,184 | 9,300 | 6,570 | (9,951) | ||
| Loss from continuing operations before income taxes: | (4,309) | (13,157) | (15,598) | (16,132) | (6,150) | (28,871) | ||
| Income tax expense (benefit) | (8) | (8) | (14) | (2) | 124 | (2) | ||
| Other undisclosed loss from continuing operations | ||||||||
| Loss from continuing operations: | (4,317) | (13,165) | (15,612) | (16,134) | (6,026) | (28,873) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (16,134) | (6,026) | (28,873) | |
| Loss from discontinued operations | (821) | |||||||
| Other undisclosed net loss | (2,721) | |||||||
| Net loss: | (7,038) | (13,986) | (15,612) | (16,134) | (6,026) | (28,873) | ||
| Net income attributable to noncontrolling interest | 5 | 236 | 1,474 | 1,371 | 68 | |||
| Net loss available to common stockholders, diluted: | (7,038) | (13,981) | (15,376) | (14,660) | (4,655) | (28,805) | ||
Comprehensive Income ($ in thousands)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (7,038) | (13,986) | (15,612) | (16,134) | (6,026) | (28,873) | ||
| Other comprehensive income (loss) | 101 | (1) | 1 | |||||
| Comprehensive loss: | (7,038) | (13,885) | (15,612) | (16,134) | (6,027) | (28,872) | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 5 | 236 | 1,474 | 1,371 | 68 | |||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (101) | |||||||
| Comprehensive loss, net of tax, attributable to parent: | (7,139) | (13,880) | (15,376) | (14,660) | (4,656) | (28,804) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.